Skip to main content
. Author manuscript; available in PMC: 2018 Jan 30.
Published in final edited form as: Stat Med. 2016 Feb 29;36(2):215–224. doi: 10.1002/sim.6910

TABLE 4.

One agent, Single endpoint (DLT)

Next recommended dose is the dose having a mean posterior probability of DLT closest to 30%

3 participants by cohort, dose skipping allowed (limited to 200mg)

Cohort Dose (mg) Number of observed DLT Next dose level proposed (mg)

1 100 0 300
1 200
2 50
3 50

2 (0 DLT in cohort 1) 300 0 500
1 500
2 300
3 100

3 (0 DLT in cohort 1 and 2) 500 0 700
1 600
2 500
3 400

4 (0 DLT in cohort 1, 2 and 3) 700 0 900
1 800
2 700
3 600